Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 48.61 CNY 0.45%
Market Cap: 310.1B CNY

Intrinsic Value

The intrinsic value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock under the Base Case scenario is 32.83 CNY. Compared to the current market price of 48.61 CNY, Jiangsu Hengrui Pharmaceuticals Co Ltd is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
32.83 CNY
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jiangsu Hengrui Pharmaceuticals Co Ltd

Jiangsu Hengrui Pharmaceuticals Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Jiangsu Hengrui Pharmaceuticals Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
CN
Pharmaceuticals
Market Cap
310.1B CNY
IPO
Oct 18, 2000
CN
Pharmaceuticals
Market Cap
310.1B CNY
IPO
Oct 18, 2000
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Jiangsu Hengrui Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Jiangsu Hengrui Pharmaceuticals Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jiangsu Hengrui Pharmaceuticals Co Ltd

Current Assets 34.8B
Cash & Short-Term Investments 23.3B
Receivables 7.5B
Other Current Assets 4B
Non-Current Assets 13.4B
Long-Term Investments 1.5B
PP&E 7B
Intangibles 4.2B
Other Non-Current Assets 702.3m
Efficiency

Free Cash Flow Analysis
Jiangsu Hengrui Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jiangsu Hengrui Pharmaceuticals Co Ltd

Revenue
26B CNY
Cost of Revenue
-3.9B CNY
Gross Profit
22.1B CNY
Operating Expenses
-16.2B CNY
Operating Income
5.8B CNY
Other Expenses
-392m CNY
Net Income
5.4B CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jiangsu Hengrui Pharmaceuticals Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive ROIC
61/100
Profitability
Score

Jiangsu Hengrui Pharmaceuticals Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jiangsu Hengrui Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Jiangsu Hengrui Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd

Wall Street analysts forecast Jiangsu Hengrui Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 60.46 CNY with a low forecast of 45.15 CNY and a high forecast of 129.15 CNY.

Lowest
Price Target
45.15 CNY
7% Downside
Average
Price Target
60.46 CNY
24% Upside
Highest
Price Target
129.15 CNY
166% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jiangsu Hengrui Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock?

The intrinsic value of one Jiangsu Hengrui Pharmaceuticals Co Ltd stock under the Base Case scenario is 32.83 CNY.

Is Jiangsu Hengrui Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 48.61 CNY, Jiangsu Hengrui Pharmaceuticals Co Ltd is Overvalued by 32%.

Back to Top